Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (271-280 of 451) with videos related to

Pageof 46
Sort By:
Acta Neuropathologica|May 12, 2023
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasJustin Z Wang, Vikas Patil, Jeff Liu, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Cancer Letters|September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastomaObada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Neurological Research and Practice|October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasNiklas Grassl, Katharina Sahm, Heike Süße, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Oncotarget|December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testingFlorian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Neuro-Oncology|August 17, 2022
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomasMark W Youngblood, Anh N Tran, Wenxia Wang, et al.
Pageof 46

Showing results (271-280 of 451) with videos related to

Sort By:
Pageof 46
Acta Neuropathologica|May 12, 2023
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasJustin Z Wang, Vikas Patil, Jeff Liu, et al.
Acta Neuropathologica|September 8, 2021
Molecular profiling of pediatric meningiomas shows tumor characteristics distinct from adult meningiomasElmar Kirches, Felix Sahm, Andrey Korshunov, et al.
Cancer Letters|September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastomaObada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Neurological Research and Practice|October 18, 2023
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasNiklas Grassl, Katharina Sahm, Heike Süße, et al.
Acta Neuropathologica|July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusionsDamian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Acta Neuropathologica|April 12, 2013
Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 proteinLeonille Schweizer, Christian Koelsche, Felix Sahm, et al.
Oncotarget|December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testingFlorian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Acta Neuropathologica|October 25, 2013
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous systemChristian Koelsche, Felix Sahm, David Capper, et al.
Neuro-Oncology|August 17, 2022
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomasMark W Youngblood, Anh N Tran, Wenxia Wang, et al.
Pageof 46